Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

In a statement, Astellas said that the FDA had indicated that it would not be able to approve the marketing application in its current form by today's deadline (19th November) because of "a ...